Craft
  • Home
  •  / Quentis Therapeutics
Quentis Therapeutics

Quentis Therapeutics

Total Funding

$48 M

Quentis Therapeutics Summary

Company summary

Overview
Quentis Therapeutics develops immunotherapies targeting the endoplasmic reticulum stress response to awaken the immune system’s ability to fight cancer. The Company is at the forefront of the next generation of immuno-oncology companies that are translating novel biology into therapeutic approaches.
Type
Private
Founded
2016
HQ
New York, NY, US | view all locations
Website
http://www.quentistx.com/
Cybersecurity rating
Sectors

Key people

  • Michael Aberman

    Michael Aberman, President, CEO and Director

    • Juan Cubillos-Ruiz

      Juan Cubillos-Ruiz, Advisor and Scientific Founder

      • Jeanne Magram

        Jeanne Magram, Chief Scientific Officer

        LocationsView all

        1 location detected

        • New York, NY HQ

          United States

          430 E 29th St #1005

        Blogs

        Footer menu